Last reviewed · How we verify
NCT03740633
Functional Training for the Prevention of Deep Venous Thrombosis
Phase 3 trial testing passive ankle pump motions on the day of surgery in Ankle Motion in 398 participants. Status unknown.
10 November 2019
Quick facts
| Lead sponsor | Lei Li |
|---|---|
| Phase | Phase 3 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 398 |
| Start date | 10 November 2018 |
| Primary completion | 10 November 2019 |
| Estimated completion | 10 November 2019 |
| Sites | 1 location across China |
Drugs / interventions tested
- passive ankle pump motions on the day of surgery
- active ankle pump motions and abdominal breathing training on the 1-3 day after the surgery
- Regular care
Conditions studied
- Ankle Motion — all drugs for Ankle Motion →
- Gynecologic Neoplasm — all drugs for Gynecologic Neoplasm →
- Deep Venous Thrombosis — all drugs for Deep Venous Thrombosis →
- Abdominal Breathing — all drugs for Abdominal Breathing →
Sponsor
Lei Li — full company profile →
Who can join
18 and older, female only, with Ankle Motion or Gynecologic Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to analyze the post-operative functional training on the prevention of deep venous thrombosis (DVT) in the patients who have accepted major surgeries for the gynecological malignancies. The functional training consists of: (1) active and passive ankle pump motions including flexion and extension, circumduction; (2) abdominal breathing training. The primary end is the incidence of DVT happened 30 days from surgery. The secondary ends include the patients satisfaction about functional training.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03740633
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Lei Li trials
Trials by the same sponsor.
- NCT06558019 — Exosome-based OCS Scores for Predicting Ovarian Cancer Recurrence · not yet recruiting
- NCT06557954 — Cervical Cytology DNA Methylation for Cervical Cancer Screening · not yet recruiting
- NCT05801263 — ctDNA Methylation for Epithelial Ovarian Cancer · unknown
- NCT05801276 — ctDNA Methylation for Detecting Ovarian Cancer · unknown
- NCT06490380 — HRD Status Reference Standard Based on WGS · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03740633 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lei Li
- Last refreshed: 14 November 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03740633.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing